← Current compounder rows

Current NDC auxiliary source row compounder:3047

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
72934-1313
Product Ndc
72934-1313
Product Ndc Digits
729341313
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
Deoxiademtar Gel
Proprietary Name Suffix
[empty]
Nonproprietary Name
011216 CLINDAMYCIN 1% / NIACINAMIDE 4% / SPIRONOLACTONE 2% / TRETINOIN 0.025% Gel
Dosage Form Name
GEL
Route Name
TOPICAL
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
SKNV
Establishment Name
SKNV
Establishment Fei
[empty]
Substance Name
CLINDAMYCIN PHOSPHATE; NIACINAMIDE; SPIRONOLACTONE; TRETINOIN
Active Ingredients Info
1 g/100 mL; 4 g/100 mL; 2 g/100 mL; .025 g/100 mL
History Active Ingredients Raw
CLINDAMYCIN PHOSPHATE; NIACINAMIDE; SPIRONOLACTONE; TRETINOIN
History Active Ingredients Info Raw
1 g/100 mL; 4 g/100 mL; 2 g/100 mL; .025 g/100 mL
History Dosage Raw
GEL
Dea Schedule
[empty]
Package Ndc Raw
72934-1313-2
Package Ndc
72934-1313-2
Package Ndc Digits
7293413132
Package Ndc11
72934131302
Package Description
30 mL in 1 BOTTLE, PUMP (72934-1313-2)
Reporting Period Raw
2024-2
Reporting Period
2024-2
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:3047
Source Row Number
3047
Source Row Hash
1709e2eb17d17ba920f6f1a18f5ff6164e7d7d2dc3081cd5f61225744825016b
Import Run Id
20261116T204628Z
Loaded At
2026-11-16 20:58:00

Exact raw FDA source fields#

{
    "ROUTENAME": "TOPICAL",
    "PRODUCTNDC": "72934-1313",
    "DEASCHEDULE": "",
    "LABELERNAME": "SKNV",
    "SUBSTANCENAME": "CLINDAMYCIN PHOSPHATE; NIACINAMIDE; SPIRONOLACTONE; TRETINOIN",
    "DOSAGEFORMNAME": "GEL",
    "NDCPACKAGECODE": "72934-1313-2",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Deoxiademtar Gel",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "011216 CLINDAMYCIN 1% / NIACINAMIDE 4% / SPIRONOLACTONE 2% / TRETINOIN 0.025% Gel",
    "PACKAGEDESCRIPTION": "30 mL in 1 BOTTLE, PUMP (72934-1313-2) ",
    "ACTIVEINGREDIENTSINFO": "1 g/100 mL; 4 g/100 mL; 2 g/100 mL; .025 g/100 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:3047
Source Row Number
3047
Status Scope
package
Lookup Ndc
72934-1313-2
Lookup Ndc Digits
7293413132
Product Ndc
72934-1313
Product Ndc Digits
729341313
Package Ndc
72934-1313-2
Package Ndc Digits
7293413132
Package Ndc11
72934131302
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2024-2
Reporting Period
2024-2
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
1709e2eb17d17ba920f6f1a18f5ff6164e7d7d2dc3081cd5f61225744825016b
Import Run Id
20261116T204628Z
Loaded At
2026-11-16 20:58:00